Click Here to Register »

Executive Sponsors

Aptiv Solutions
CRF Health
Medidata

Associate Sponsors

DrugDev
ePharmaSolutions
goBalto
Greenphire
iCTRS
MedPoint Digital
MMG
Patient Profiles
Sanguine BioSciences
Spaulding Clinical
Target Health
Veeva Systems

Supporting Sponsor

PAREXEL International

Soapbox Sponsor

Phlexglobal Ltd.

Exhibitors

MobileSmith
PCM Trials
Trifecta

Media Partners

BioCentury
BioPharm Clinical
BioPortfolio
Bloomberg Brief
Can Biotech
CenterWatch
Clinical Informatics News
HealthEconomics
International Clinical Trials
Larta Institute
Life Science Leader
Massachusetts Life Science Center
MassBio
Medical News Today
Pharmaphorum
Pharmavoice
Rebar Interactive
Technology Networks
Trials

Overview

 

Co-Chairs

Jeff KasherJeff Kasher, PhD
VP & COO
Eli Lilly
Andreas KoesterAndreas Koester,
MD, PhD

VP, Clinical Trial Innovation & External Alliances
Janssen
Craig LipsetCraig H. Lipset
Head of Clinical Innovation, R&D
Pfizer, Inc.
Jphn OrloffJohn Orloff, MD
SVP, Global Development & CMO
Novartis Pharma AG

 

“Disruptive innovations transform complicated, expensive products into simpler and more affordable ones.”HBS Professor Clayton Christensen

About the Conference

The Conference Forum’s Dpharm: Disruptive Innovations to Advance Clinical Trials event is now in its 4th year and is the only program truly dedicated to the development of a program that demonstrates disruption in clinical trials. The conference brings together an exceptional audience of out-of-the-box thinkers determined to make clinical trials more affordable, efficient with higher quality data and a far better experience for patients.

It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results. This conference is designed to be engaging in a highly informative format, similar to the style of TED events. Each session will deliver a clear set of objectives, summary and key take-aways.

Focus & Objectives

  • This is a TED-style event showcasing innovations and leading practitioners in Pharma R&D with a focus on clinical research as well as innovative leaders from other industries.
  • We strive to underscore the promise and challenge of innovation in advancing drug development.
  • We strive to innovate a new model and find collaborations to get therapeutics to patients faster.
  • We address how can we better apply the full spectrum of clinical research options and utilize insights more appropriately.
  • We are dedicated to designing creative solutions and finding a way to implement them.
  • We explore to whom are companies being disruptive to and gain a better understanding of the impact on clinical trials.

Each year, dozens of conferences and meetings are held to discuss specific challenges within clinical trials. Many events are tactical in nature, focusing independently on topics ranging from financing approaches, protocol design, partnering models between sponsors and clinical trial sites, technology trade shows, etc. By focusing on narrow aspects of clinical trials, past conferences have not effectively taken the necessary high-level, systemic view needed to identify innovations that can leapfrog inefficiencies in clinical trials. We invite you to explore the 2013 agenda, visit our newsletter and let us know if you have any questions or ideas to share. Contact us at service@theconferenceforum.org

Registration is open for the 2014 event at early discounted rates.


Testimonials

  • "The Disruptive Innovations conference was a great experience for me as an academic cardiologist, trialist and global health researcher."

    - Sameer Bansilal, MD, MS, Zena and Michael A Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai

  • "It's really a pleasure to be part of what I am beginning to think may be the best industry conference for the money."

    - Joseph Kim, Shire

  • "What’s great about the Disruptive Innovations conference is that it addresses all innovation ingredients."

    - Rahlyn Gossen, Rebar Interactive

  • "Thank you. The DPharm and Global Clinical Trials events were outstanding.  Your team have once again surpassed my expectations and delivered an event above and beyond anything else in the industry."

    - Elan Josielewski, CRF Health

  • "Thank you for inviting me to an amazing experience.  I am truly inspired and humbled by the incredible people that I met during the conference that are persevering through numerous obstacles to transform our industry. It makes me very hopeful that we will evolve and not be dinosaurs that become extinct."

    - Komathi Stem, Genentech

  • "You put on a VERY professional meeting - congratulations!"

    - Adrian McKemey, Quintiles

  • "Thanks for a great conference."

    - Zen Chu, MIT

  • "My overall rating is A+!  It was great and my brain was full by the time I boarded the plane to come home!  Great for personal brainstorming and encouraging thinking out of the box."

    - Susan Romberg, RPS

  • "It was a great journey to navigate across the innovative initiatives happening across the healthcare/lifescience industry."

    - MaryAnne Rizk, PhD, Stevens Institute of Technology

  • "Overall,well organized and has a good spirit of innovation."

    - Jerry Matczak, Eli Lilly

  • "Once again, let me tell you how much I enjoyed the conference. I took the ‘disruptive’ style of presentations at the meeting and adapted it to a presentation I gave to my colleagues in personalized medicine."

    - Kiran Dole, PharmD, Novartis Institute for biomedical Research

  • "Great conference, wonderful presenters and topics and I especially liked the people featured from other industries."

    - Caroline Manning, Merck

  • "Excellent conference. I would love to contribute and/or attend again. Great dialogue."

    - Jeff Kingsley, SERRG

  • "Great networking opportunity."

    - Brett Kleger, DrugDev

  • "Great conference, would come again! It was an awesome event! Exceeded my expectations. Venue was perfect and content was truly innovative."

    - Marcella Lynch, Shire

  • "My colleague and I were last minute attendees at Dpharm, and we are so glad that we went. We felt at home among kindred spirits trying to accomplish something new, challenging, different, and disruptive."

    - Brendan Kelleher, Karmadata

  • "Excellent! Real Disruption! Refreshing!"

    - Thomas Krohn, Eli Lilly

  • "Kudos to the Conference Forum, Craig, John and Andreas for a truly fresh perspective on our industry. It has been very energizing and without tired topics. The format and content are top-notch and sophisticated. Well worth taking the time to attend."

    - Deirdre BeVard, Endo Pharmaceuticals

  • "This conference was a very good mix of inspirational and specific nitty – gritty. WOW!"

    - Veronica Ludensky, Takeda / Millenium

  • "Thank you! Excellent. The best conference I have attended in the last few years!"

    - Maria Makarovskaya, Cubist Pharmaceuticals

  • "This was the first conference I attended in a very long time where I left feeling hopeful."

    - Tomasz Sablinksi, MD, PhD, Celtic Therapeutics

  • "Information was new and fresh and the participants were all very eager to hear about innovations that could drive improvements in clinical trials - very interactive group within the meeting and the breaks. Great job organizing."

    - Kathy Forde , Spaulding Clinical

  • "Extremely relevant, helpful and engaging."

    - Tom Kaminski, Duke Clinical Research

  • "Wonderful insight into issues of innovation, well presented, excellent passionate talks."

    - Michael Montgomery, Janssen Biotech

  • "Good presentations and presentation styles."

    - Steven Najda, Roche

  • "Speakers were excellent at connecting with the audience."

    - Robert Wright, Life Science Leader

  • "Excellent Introduction, Thanks to all speakers and conference organizers."

    - David Smithwick, Duke Clinical Research

  • "Good topics and speakers. Thinking outside the box. My first DPharm conference, very impressive."

    - Stephen Goodman, Pryor Cashman

  • "Relaxed agenda pace, I really enjoyed listening to the patient’s perspective. The talk from MJ Fox Foundation and Patients Like Me were very good."

    - George Vratsanov, Roche

  • "A conference with vision, greatly appreciate view and synthesis."

    - Greg Simon, Pfizer